BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial
Felix Keil(Hanusch Hospital), Thomas Pabst(University Hospital of Bern), J. C. Schuster(Wilhelminen Hospital), Markus F. Rütti(WiLAN (Canada)), Richard Greil(Paracelsus Medical University), Michael Panny(Hanusch Hospital), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Thomas Nösslinger(Hanusch Hospital), Corinne Vorburger(University Hospital of Bern), Regina Riedl(Medical University of Graz), Celine Bencker(Hanusch Hospital), Panagiotis Samaras(University Hospital of Zurich), Andrea Berghold(Medical University of Graz), Alexandra Böhm(Krankenhaus der Elisabethinen), Antonia Müller(University Hospital of Zurich)
Cited by 6
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Summary of constitutional data on the Aluminum-Carbon-Titanium system
|Journal of Phase Equilibria|1994|441